JAK3 and rheumatoid arthritis: Inhibiting JAK3 or JAK1 decreases the production of pro-inflammatory cytokines such as interleukin-6 and interleukin IL-17, two key cytokines in rheumatoid arthritis (Henderson Berg et al., 2022; Kotyla et al., 2022).